Investors with a lot of money to spend have taken a bearish stance on GSK (NYSE:GSK). And retail traders should know. We noticed this today when the positions showed up on publicly available options ...

GSK (LSE:GSK) has received FDA approval for Lynavoy (linerixibat), the first treatment in the US for cholestatic pruritus in ...

Investors in GSK plc (Symbol: GSK) saw new options begin trading today, for the August 8th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GSK options chain for ...

Technical indicators for Pfizer and GSK have turned bullish.

GSK (LSE:GSK) secured Chinese approval for Exdensur for severe asthma patients aged 12 and older. The company also had its ...

Wave Life Sciences Ltd. (NASDAQ:WVE) stock is trading lower on Wednesday after the company shared data from the ongoing Phase 1b/2a RestorAATion-2 Trial of WVE-006 in alpha-1 antitrypsin deficiency.

GSK PLC closed 13.37% short of its 52-week high of £22.82, which the company achieved on February 18th.